Controlled Human Malaria Infection Administered by Mosquito Bite

OTHER2 trials

Sponsors

University of Oxford

Conditions

Plasmodium Falciparum Malaria

Phase 1

A Challenge Study to Assess the Protective Efficacy of Two Malaria Vaccine Candidates

CompletedNCT01623557

University of OxfordPlasmodium Falciparum Malaria

Start: 2012-04-30End: 2012-11-30Updated: 2015-02-16

A Phase I/IIa Sporozoite Challenge Study to Assess the Efficacy of Candidate Combination Malaria Vaccine Approaches Using the ChAd63 and MVA Vectors Encoding the Antigens ME-TRAP, CS and AMA1

CompletedNCT01739036

University of OxfordPlasmodium Falciparum Malaria

Start: 2013-01-31End: 2013-10-31Updated: 2013-11-11

Related Papers

Evaluation of the Efficacy of ChAd63-MVA Vectored Vaccines Expressing Circumsporozoite Protein and ME-TRAP Against Controlled Human Malaria Infection in Malaria-Naive Individuals

The Journal of Infectious Diseases2014-10-21127 citations

Evaluation of the Efficacy of ChAd63-MVA Vectored Vaccines Expressing Circumsporozoite Protein and ME-TRAP Against Controlled Human Malaria Infection in Malaria-Naive Individuals

Oxford University Research Archive (ORA) (University of Oxford)2014-10-21